The Pharma Letter2d
Nykode gets back rights VB10.NEO program from Genentech
Norwegian clinical-stage biotech Nykode Therapeutics revealed that it has received notification from Genentech, a US ...
Genentech terminates agreement for Nykode cancer vaccine program
Nykode Therapeutics (VACBF) announced last night that it has received notification from Genentech, a member of the Roche (RHHBY), of its ...
FierceBiotech5d
In 'surprise' termination, Genentech drops Nykode partnership for individualized cancer vaccine
Roche’s Genentech is ending a partnership with Nykode Therapeutics that centered around a clinical-stage cancer vaccine ...
ENDPOINTS NEWS6d
Dai­ichi, Al­teogen to work on sub­cu­ta­neous En­her­tu; Roche ends Nykode deal
Plus, news about Disc Medicine, AlloVir, Kalaris, Travere Therapeutics and Trevena: Daiichi Sankyo, Alteogen to develop subcutaneous version of Enhertu: Daiichi will pay $20 million upfront to the ...